二尖瓣修复与置换:英国2000至2019年20年结局趋势
利用英国大型国家数据库描述2000至2019年二尖瓣手术的结局趋势,队列按四年入院期分为A至E组。共63000例患者,其中二尖瓣修复31644例、置换31356例。修复与置换的院内死亡率均随时间显著下降,修复已成为更常见术式;女性修复率较低且修复后死亡率较高,感染性心内膜炎发生率上升。
要点
- 二尖瓣修复与置换的院内死亡率均随时间显著下降,时间期为独立预测因素。
- 女性修复率低于男性(49% vs 67%,P < 0.001),修复后死亡率高于男性(3% vs 2%,P = 0.001)。
- 病因向退行性病变转变,修复组感染性心内膜炎发生率初期下降后上升(A期6%、C期4%、E期6%,P < 0.001)。
核心结论
- 英国二尖瓣手术的院内死亡率随时间显著下降,二尖瓣修复已成为更常见术式。
- 修复率与死亡率的性别差异需进一步研究,二尖瓣手术中感染性心内膜炎发生率正在上升。
研究设计与样本
- 基于英国大型国家数据库的队列研究,纳入2000至2019年二尖瓣手术患者,不论是否合并其他手术。
- 队列按四年入院期分为A至E组,比较二尖瓣修复与置换,主要结局为院内死亡,次要结局为重返手术室、术后卒中和术后住院时间。
- 采用多变量二元逻辑回归模型评估死亡与时间的关系,并按性别和病因分层。
主要发现
- 研究队列共63000例患者,其中二尖瓣修复31644例、二尖瓣置换31356例。
- 未调整术后死亡率在修复组从5%降至2%(P < 0.001),在置换组从9%降至7%(P = 0.015)。
- 时间期是修复组死亡降低的独立预测因素(比值比0.41,95%置信区间0.28-0.61,P < 0.001),也是置换组死亡降低的独立预测因素(比值比0.50,95%置信区间0.41-0.61,P < 0.001)。
- 最新时间期女性修复率低于男性(49% vs 67%,P < 0.001),且接受修复的女性死亡率高于男性(3% vs 2%,P = 0.001)。
- 修复组感染性心内膜炎发生率初期下降后上升(A期6%、C期4%、E期6%,P < 0.001),合并症负担随时间增加。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Using a large national database, we sought to describe outcome trends in mitral valve surgery between 2000 and 2019. METHODS: The study cohort was split into mitral valve repair (MVr) or replacement, including all patients regardless of concomitant procedures. Patients were grouped by four-year admission periods into groups (A to E). The primary outcome was in hospital mortality and secondary outcomes were return to theatre, postoperative stroke and postoperative length of stay. We investigated trends over time in patient demographics, comorbidities, intraoperative characteristics and postoperative outcomes. We used a multivariable binary logistic regression model to assess the relationship between mortality and time. Cohorts were further stratified by sex and aetiology. RESULTS: Of the 63 000 patients in the study cohort, 31 644 had an MVr and 31 356 had a replacement. Significant demographic shifts were observed. Aetiology has shifted towards degenerative disease; endocarditis rates in MVr dropped initially but are now rising (period A = 6%, period C = 4%, period E = 6%; P < 0.001). The burden of comorbidities has increased over time. In the latest time period, women had lower repair rates (49% vs 67%, P < 0.001) and higher mortality rates when undergoing repair (3% vs 2%, P = 0.001) than men. Unadjusted postoperative mortality dropped in MVr (5% vs 2%, P < 0.001) and replacement (9% vs 7%, P = 0.015). Secondary outcomes have improved. Time period was an independent predictor for reduced mortality in both repair (odds ratio: 0.41, 95% confidence interval: 0.28-0.61, P < 0.001) and replacement (odds ratio: 0.50, 95% confidence interval: 0.41-0.61, P < 0.001). CONCLUSIONS: In-hospital mortality has dropped significantly over time for mitral valve surgery in the UK. MVr has become the more common procedure. Sex-based discrepancies in repair rates and mortality require further investigation. Endocarditis rates in MVS are rising.
引用
- Al-Zubaidi F, Pufulete M, Sinha S, et al. Mitral repair versus replacement: 20-year outcome trends in the UK (2000-2019). Interdiscip Cardiovasc Thorac Surg. 2023. PMID: 37208195. doi:10.1093/icvts/ivad086
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。